Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Dear Colleague
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine February 1998, 65 (2) 62;
  • You have access
    An overview of immune hemolytic anemias
    Ronald E. Domen, MD
    Cleveland Clinic Journal of Medicine February 1998, 65 (2) 89-99;

    Often patients with these anemias present with symptoms that are common in anemia of any cause. A full-color illustration shows the different processes of red blood cell destruction.

  • You have access
    Detecting and managing subclinical hyperthyroidism
    Hussein Saadi, MD, FACP
    Cleveland Clinic Journal of Medicine February 1998, 65 (2) 65-66;

    With physicians using TSH assays more often, they are encountering subclinical thyroid disease more frequently.

  • You have access
    Cancer and the mind: Separating fact from fiction
    Cleveland Clinic Journal of Medicine February 1998, 65 (2) 107-109;

    It is quite appropriate for physicians to encourage cancer patients to join support groups. However, these patients should not blame themselves or their emotions for causing the cancer.

  • You have access
    Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Ray W. Gifford, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 18-24;

    The JNC VI report updates the standard of care in hypertension, advising physicians to be more diligent in lowering blood pressure, especially in patients with known risk factors.

  • You have access
    A proper role for organized medicine (May 1997) Editorial
    W. Jeanne McKibben, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 49-50;
  • You have access
    Chronic lymphocytic leukemia: A brief review
    John C. Krauss, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 42-48;

    CLL, the most common type of leukemia, is often discovered incidentally when a routine complete blood count is performed. This paper reviews the pathology, diagnosis, and treatment of CLL.

  • You have access
    In response: A proper role for organized medicine (May 1997) Editorial
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 50;
  • You have access
    Protoivpump inhibitors for gastric acid-related disease
    Thomas G. Franko, MS and Joel E. Richter, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 27-34;

    Proton-pump inhibitors are the most effective drugs for suppressing gastric acid production. Concerns over potential ill effects of hypergastrinemia have proved unfounded.

  • You have access
    Dear Colleague
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine January 1998, 65 (1) 8;

Pages

  • Previous
  • Next
  • 1
  • …
  • 443
  • 444
  • 445
  • 446
  • 447
  • 448
  • 449
  • 450
  • 451
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire